Tim Gallagher

Company: PhosphoGam

Job title: Chief Business Officer

Seminars:

Panel Discussion: Understanding the Merits & Feasibilities of HLA Matching 11:30 am

Explore the importance of HLA matching in improving patient outcomes and reducing the risk of allogeneic rejection in allogeneic therapies Evaluate the feasibility and logistical considerations of implementing HLA matching in clinical settings to optimize donor-recipient compatibility Discuss recent advancements and tools that facilitate HLA matching processes, enhancing the overall efficacy of allogeneic treatmentsRead more

day: Day Two - Track A AM

Panel Discussion: Ensuring Lasting Therapeutic Responses from Allogeneic Therapy – Is Redosing the Way to Go? 8:30 am

Examine the role of redosing in sustaining therapeutic efficacy and preventing disease relapse in patients receiving  allogeneic therapies How do we determine if multiple doses are needed and if so, how do we determine how many? Is it better to use a one and done model or plan for multiple doses? Analyze the impact of…Read more

day: Conference Day Two

Closing Remarks 4:00 pm

Read more

day: Conference Day Two

Maximizing Cell Viability by Preventing Exhaustion During Cell Expansion 1:30 pm

Explore innovative techniques to monitor cellular health and functionality throughout the expansion process Discover the impact of culture media and environmental factors on preventing cell fatigue and maintaining robust performanceRead more

day: Day Two - Track B PM

Opening Remarks 8:00 am

Read more

day: Conference Day One